What is MaxCyte's investment purchases?

MaxCyte (MXCT) reported investment purchases of $25.12M in Q1 2026.

How has MaxCyte's investment purchases changed year-over-year?

MaxCyte's investment purchases decreased by 27.5% year-over-year, from $34.65M to $25.12M.

What is the long-term trend for MaxCyte's investment purchases?

Over 2 years (2023 to 2025), MaxCyte's investment purchases has grown at a -29.6% compound annual growth rate (CAGR), from $255.1M to $126.29M.

What does investment purchases mean?

Cash spent purchasing investment securities across all categories.

MaxCyte MXCT Investment Purchases

Investment Purchases at other companies

Bio-Rad LaboratoriesBIO

$226.1M+47.4%

Thermo Fisher ScientificTMO

$14M-94.7%

Ginkgo BioworksDNA

$83.16M-56.5%

Immix Biopharma, Inc.IMMX

$7.77M+379%

Rapid Micro BiosystemsRPID

$3.02M—

Prime MedicinePRME

$7.28M-84.9%

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's investment purchases?: MaxCyte (MXCT) reported investment purchases of $25.12M in Q1 2026.
How has MaxCyte's investment purchases changed year-over-year?: MaxCyte's investment purchases decreased by 27.5% year-over-year, from $34.65M to $25.12M.
What is the long-term trend for MaxCyte's investment purchases?: Over 2 years (2023 to 2025), MaxCyte's investment purchases has grown at a -29.6% compound annual growth rate (CAGR), from $255.1M to $126.29M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.